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carotid artery intima-media thickness (CCA-IMT) and the
ankle-brachial index (ABI) were separately associated with
outcome after vascular surgery. Aim of the study was to
evaluate if these risk markers have an added predictive value
even on top of the RCR index.
Methods: A total of 647 patients with hs-CRP, CCA-
IMT and ABI assessment prior to surgery were included.
The primary endpoint was a composite of cardiac death and
non-fatal myocardial infarction.
Results: Based on multivariate hazard ratios (HRs), a
baseline hs-CRP6.5 mg/l was not predictive of a 30-day
cardiac event, in contrast with a CCA-IMT1.25mm and
an ABI0.91. However, all three risk markers had a signif-
icant association with long-term adverse outcome (Table).
Hazard ratios (HR) and odds ratios (OR) for cardiac
events after vascular surgery
30-day events HR 95% CI p-value
Cumulative
2
Revised cardiac risk
index 1.65 1.39-1.95 0.001 98.9
hs-CRP 6.5mg/l 1.10 0.82-1.49 0.521 99.3
CCA-IMT 1.25 1.44 1.07-1.94 0.016 105.1
ABI 0.90 2.05 1.53-2.74 0.001 125.2
Long-term events OR 95% CI p-value
Cumulative
2
Revised cardiac risk
index 1.69 1.45-1.98 0.001 152.4
hs-CRP 6.5mg/l 1.53 1.17-2.00 0.002 163.8
CCA-IMT 1.25 2.40 1.84-3.12 0.001 176.5
ABI 0.90 2.21 1.69-2.89 0.001 209.6
Multivariate analysis corrected for gender, age, hypertension, hypercholes-
terolemia, smoking and chronic obstructive pulmonary disease.
Conclusions:The current results show that combining
risk markers with risk factors as embedded in cardiac risk
indices can improve perioperative and long-term risk pre-
diction in vascular surgery patients. These additions to risk
prediction models should be investigated in other
populations.
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Objectives: To determine the viability, safety, and ef-
ficacy of various forms of atherectomy devices over a 5 year
period in the treatment of lower extremity arterial occlusive
disease. In addition, to determine if EPD use confers any
benefit with regards to distal embolization during the
atherectomy procedure.
Methods: Retrospective review of 150 limbs in 148
patients treated with atherectomy at a single institution
over a 5 year period. The atherectomy devices included
laser, rotational, and orbital atherectomy. Patient charac-
teristics, type of device used, success of delivery of atherec-
tomy device to target lesion, reconstruction techniques,
rate and type of complications, and subsequent procedures
were all examined. The use of EPD’s in atherectomy pro-
cedures were also examined with regard to the rate of distal
embolization.
Results:Median age of patients was 64.80% were male.
Successful delivery of atherectomy device to target lesion
was 93.3% (n140). The limb level of atherectomy inter-
vention was the superficial femoral artery in 60.7% (n91).
Median length of vessel treated was 12 cm. Majority of
reconstruction following atherectomy was balloon angio-
plasty alone in 63.3% (n95). Reconstruction success was
86.7% Vessel rupture or extravasation was seen in 13.3%.
78% of limbs did not require any further intervention. Rate
of major amputation after atherectomy was 9.3%. 26.7% of
limbs (n40) received an EPD prior to atherectomy, while
73.3% (n110) did not. The rate of distal embolization
was 12.5% in the EPD group and 15.5% in the non-EPD
group (p0.65, NS).
Conclusions: Atherectomy is a safe, viable, and effec-
tive method of intervention for lower extremity arterial
occlusive disease. The majority of patients required angio-
plasty alone as reconstruction after atherectomy. Subse-
quent rates of futher intervention or amputations were low.
In the embolic protection substudy, there was no signifi-
cant difference in the rate of distal embolization between
patients treated with or without an EPD.
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